William D. Chey of the University of Michigan Medical Center, Ann Arbor, Michigan and Dr. Paul Moayyedi of McMaster University, Hamilton, Ontario, Canada. The stated aim of the Co-Editors is to meet the evolving educational needs of the ACG membership and gastroenterologists in clinical practice. “The steady growth in the impact factor for The American Journal of Gastroenterology underscores the rigor of the review process and the quality and relevance of the articles published,” commented ACG President Lawrence R. Schiller, M.D., FACG. “The Red Journal is considered essential reading for clinical gastroenterologists and the College is proud of its reputation for high caliber clinical science on digestive diseases and conditions.” The journal’s Co-Editors-in-Chief, Dr. Moayyedi and Dr. Chey, commented, “We are delighted that the impact factor for AJG continues to increase. The Associate Editors and all the editorial team work tirelessly to attract and publish the best science in the Red Journal. Our impact factor confirms that the Red Journal is the top journal to publish original clinical GI science.” A guide to interpreting the impact factor as a quantitative approach to evaluating scientific journals from Thomson Reuters can be found here: http://thomsonreuters.com/products_services/science/free/essays/impact_factor/ Digital Tools Enhance the Reach of AJG Clinical Science for GI Clinicians This year the Co-Editors of The American Journal of Gastroenterology introduced two new features to expand the reach the Journal using digital media. A new Author Podcast Series launched in March highlights noteworthy articles and engages authors in a lively discussion with one of the Co-Editors each month and can be accessed via the ACG Web site , via the Nature AJG site and via iTunes . A new Virtual Journal Club inaugurated in May offers an online forum to discuss the latest clinical GI science from The American Journal of Gastroenterology. Members of the American College of Gastroenterology can become part of this online community and engage with colleagues, post questions and start discussions. Chey, MD, AGAF, FACG, FACP of the University of Michigan and Paul Moayyedi, BSc, MB ChB, PhD, MPH, FRCP, FRCPC, FACG of McMaster University. SOURCE American College of Gastroenterology
Mauna Kea Technologies Announces Strong Presence at Asia-Pacific Digestive Week / World Congress of Gastroenterology 2013
Several hundreds of our patients have already benefited from Optical Biopsies. The scientific exposure this year at APDW is already very significant, reflecting the high-quality clinical work performed around the world with probe-based Confocal Laser Endomicroscopy. Cellvizio and its miniprobes will be on display at booth #E01, together with Fujifilm China, its exclusive distributor in China. In China, like in the rest of world, gastroenterologists are now given the possibility to improve some of the most important procedures for their patients, thanks to Optical Biopsy. There is also clear evidence that only a short learning curve is required to interpret Optical Biopsy images and use it in routine, said Dr. Marc Giovannini, Chief of Endoscopy at Institut Paoli-Calmettes in Marseilles, France. Dr. Giovannini will be conducting a live procedure with Cellvizio at Changhai Hospital, The Second Military Medical University, Shanghai, in a session organized by Pr. Zhao-Shen Li, Chief of Gastroenterology at Changhai Hospital. Pr. Li is also President of the Chinese Society of Digestive Endoscopy (CSDE) and Vice President of Shanghai Chinese Society of Gastroenterology (CSGE). The very strong exposure enjoyed by Cellvizio at APDW 2013, with 13 presentations confirming the clinical value of Optical Biopsy in gastroenterology represents a key milestone in Asia-Pacific. Our presence reflects the increasing penetration of Optical Biopsy in this region, strengthened by our expanded physical representation in Asian countries, said Sacha Loiseau, CEO and Founder of Mauna Kea Technologies.